XtalPi, a leading life sciences and new materials R&D platform powered by quantum physics, AI and robotics, announces its acquisition of Liverpool ChiroChem (LCC), a pioneer in automated chiral chemistry technologies. Founded in 2014 at the University of Liverpool, UK, LCC has established itself as a global leader in high-throughput novel chiral molecule design and synthesis, serving multinational pharmaceutical companies and specialist biotech firms across the US, Europe, and Asia.
Read the full article: XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC) //
Source: https://www.prnewswire.com/news-releases/xtalpi-announces-strategic-acquisition-of-liverpool-chirochem-lcc-unlocking-unprecedented-power-in-chemical-space-exploration-302480967.html